Detection of Cytomegalovirus Virus in Neonates

A Study in Adolescent Females to Explore Cytomegalovirus Infection

NCT01691820 ·Status: COMPLETED ·Phase: NA

CMV Infection in Adolescent Males

NCT00302029 ·Status: TERMINATED

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

NCT06522880 ·Status: RECRUITING

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation

NCT03443791 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine

NCT02594566 ·Status: WITHDRAWN ·Phase: PHASE1

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

NCT03486834 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

NCT01602614 ·Status: COMPLETED

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

NCT01376778 ·Status: COMPLETED ·Phase: PHASE3

Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease

NCT00004642 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

NCT06118515 ·Status: RECRUITING ·Phase: PHASE1

Cytomegalovirus Spread and Reactivation in Blood Cells

NCT00006314 ·Status: COMPLETED

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

NCT01986010 ·Status: COMPLETED ·Phase: PHASE1

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

NCT02370758 ·Status: COMPLETED ·Phase: NA

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

NCT00006145 ·Status: COMPLETED ·Phase: PHASE3

Genotyping of Cytomegalovirus From Patients in Israel

NCT00228202 ·Status: UNKNOWN

Immune Response to Cytomegalovirus

NCT00034437 ·Status: COMPLETED

Clinical Evaluation of the QuantiFERON CMV Assay

NCT03502161 ·Status: TERMINATED

A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

NCT00001062 ·Status: COMPLETED ·Phase: PHASE1

Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV

NCT02782988 ·Status: COMPLETED

Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR

NCT00004573 ·Status: UNKNOWN ·Phase: NA

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

NCT00466817 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age

NCT01195571 ·Status: COMPLETED ·Phase: PHASE1

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

NCT04232280 ·Status: COMPLETED ·Phase: PHASE2

Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection

NCT00004278 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

NCT00001100 ·Status: COMPLETED ·Phase: PHASE3